A ROCK Inhibitor Blocks the Inhibitory Effect of Chondroitin Sulfate Proteoglycan on Morphological Changes of Mesenchymal Stromal/Stem Cells into Neuron-Like Cells.
- Author:
Hee Suk LIM
1
;
Young Ae JOE
Author Information
1. Cancer Research Institute and Department of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea. youngjoe@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Mesenchymal stromal/stem cell;
ROCK inhibitor;
Chondroitin sulfate proteoglycan;
PKC inhibitor;
Y27632
- MeSH:
Anoxia;
Chondroitin Sulfate Proteoglycans*;
Chondroitin Sulfates*;
Chondroitin*;
Humans;
Neurites;
Neurons;
Protein Kinase C;
Stem Cells
- From:Biomolecules & Therapeutics
2013;21(6):447-453
- CountryRepublic of Korea
- Language:English
-
Abstract:
Chondroitin sulfate proteoglycan (CSPG) inhibits neurite outgrowth of various neuronal cell types, and CSPG-associated inhibition of neurite outgrowth is mediated by the Rho/ROCK pathway. Mesenchymal stromal/stem cells (MSCs) have the potential to differentiate into neuron-like cells under specific conditions and have been shown to differentiate into neuron-like cells by co-treatment with the ROCK inhibitor Y27632 and the hypoxia condition mimicking agent CoCl2. In this study, we addressed the hypothesis that a ROCK inhibitor might be beneficial to regenerate neurons during stem cell therapy by preventing transplanted MSCs from inhibition by CSPG in damaged tissues. Indeed, dose-dependent inhibition by CSPG pretreatment was observed during morphological changes of Wharton's jelly-derived MSCs (WJ-MSCs) induced by Y27632 alone. The formation of neurite-like structures was significantly inhibited when WJ-MSCs were pre-treated with CSPG before induction under Y27632 plus CoCl2 conditions, and pretreatment with a protein kinase C inhibitor reversed such inhibition. However, CSPG treatment resulted in no significant inhibition of the WJ-MSC morphological changes into neuron-like cells after initiating induction by Y27632 plus CoCl2. No marked changes were detected in expression levels of neuronal markers induced by Y27632 plus CoCl2 upon CSPG treatment. CSPG also blocked the morphological changes of human bone marrow-derived MSCs into neuron-like cells under other neuronal induction condition without the ROCK inhibitor, and Y27632 pre-treatment blocked the inhibitory effect of CSPG. These results suggest that a ROCK inhibitor can be efficiently used in stem cell therapy for neuronal induction by avoiding hindrance from CSPG.
